Weight loss drugmaker to slash 9,000 jobs in £926 million cost cut
Novo Nordisk was at one point last year Europe's most valuable listed company
The Independent UK ·
Get all your news in one place.
100's of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100's of premium titles. One news app.
INSANE: 2 | Rare Historical Photos
Novo Nordisk To Cut 9,000 Jobs As Competition From Eli Lilly Heats Up: Analyst Calls Move 'Tough, Natural...Very Necessary'
Novo Nordisk (NYSE:NVO) has announced a significant restructuring plan that will see the company cut 9,000 jobs, representing 11.5% of its workforce. The decision comes as the pharmaceutical giant faces mounting pressure from U.S. competitor Eli Lilly (NYSE:LLY).
Benzinga ·
Wegovy maker Novo Nordisk to cut 9,000 jobs amid increased competition
Danish manufacturer of weight-loss and diabetes drugs under pressure from US rival Eli Lilly
The Guardian - UK ·
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Coverage From
Benzinga
The Guardian - UK
The Independent UK
The Economic Times
International Business Times
Barchart
Evening Standard
AAP
Euronews
MarketBeat
Medical Daily
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Organisations
Read news from The Economist, FT, and more,
with one subscription
with one subscription
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.
100+ trusted global sources.
